The fate of steroid estrogens: Partitioning during wastewater treatment and onto river sediments

This is the author's accepted manuscript. The final published article is available from the link below. Copyright @ 2010 Springer Science+Business Media B.V.The partitioning of steroid estrogens in wastewater treatment and receiving waters is likely to influence their discharge to, and persistence in, the environment. This study investigated the partitioning behaviour of steroid estrogens in both laboratory and field studies. Partitioning onto activated sludge from laboratory-scale Husmann units was rapid with equilibrium achieved after 1 h. Sorption isotherms and Kd values decreased in the order 17α-ethinyl estradiol > 17α-estradiol > estrone > estriol without a sorption limit being achieved (1/n >1). Samples from a wastewater treatment works indicated no accumulation of steroid estrogens in solids from primary or secondary biological treatment, however, a range of steroid estrogens were identified in sediment samples from the River Thames. This would indicate that partitioning in the environment may play a role in the long-term fate of estrogens, with an indication that they will be recalcitrant in anaerobic conditions.EPSR

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels

The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes over 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point‐in‐time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/bph.15539. Ion channels are one of the six major pharmacological targets into which the Guide is divided, with the others being: G protein‐coupled receptors, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid‐2021, and supersedes data presented in the 2019/20, 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC‐IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate

The Concise Guide to PHARMACOLOGY 2023/24: Ion channels

The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of approximately 1800 drug targets, and over 6000 interactions with about 3900 ligands. There is an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (https://www.guidetopharmacology.org/), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes almost 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point‐in‐time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.16178. Ion channels are one of the six major pharmacological targets into which the Guide is divided, with the others being: G protein‐coupled receptors, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid‐2023, and supersedes data presented in the 2021/22, 2019/20, 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC‐IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview.

The Concise Guide to PHARMACOLOGY 2017/18 is the third in this series of biennial publications. This version provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.13882/full. In addition to this overview, in which are identified 'Other protein targets' which fall outside of the subsequent categorisation, there are eight areas of focus: G protein-coupled receptors, ligand-gated ion channels, voltage-gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2017, and supersedes data presented in the 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature Committee of the Union of Basic and Clinical Pharmacology (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Resource recovery from sanitation to amplify development: Navigating global and local possibilities

Recovery of human-derived resources (e.g., nutrients, energy) from sanitation systems has emerged as an approach that may generate progress toward multiple Sustainable Development Goals (SDGs). However, persistent uncertainties and concerns (e.g., economics, social appropriateness) across a variety of scales and settings limit implementation, and failures are common. Decision-makers require more rigorous methods and tools to characterize various sanitation, recovery, and reuse options. Therefore, the overarching goals of this work are to explore and quantify the possibilities, benefits, and challenges associated with resource recovery, and to establish quantitative models and conceptual frameworks capable of contributing to global and local paths forward for sanitation. Specific objectives include (i) estimating recovery’s impacts on resource access; (ii) developing methods to define spatial co-location and transport requirements; (iii) employing spatial methods to assess soil suitability of recovery products; (iv) developing a conceptual framework linking recovery with ecosystem services; and (v) developing a social-ecological systems framework that defines sanitation as a human-derived resource system and supports multidimensional analysis across contexts. The first three objectives examine particular topics associated with resource recovery at a global scale by developing and implementing quantitative models. These analyses point toward locality-specific strategies for deriving the greatest benefit from sanitation investments, while also identifying overarching trends to guide international research efforts. First, resource recovery from sanitation systems that will need to be installed to achieve sanitation SDG targets may considerably improve access to agricultural nutrients and household energy in the least-developed countries, six of which could double or offset all projected nutrient and electricity use. Global potential nutrient gains are an order of magnitude larger than those for electricity. Second, closing urban nutrient cycles will require transport of nutrients from cities to surrounding cropland. Estimated transport distances across 56 of the world’s largest cities span two orders of magnitude and are often shorter among European, African, and Asian cities due to factors such as high local cropland density and nutrient-intensive crops. The energy requirements associated with transporting nutrients may constrain whether certain recovery strategies and products (e.g., reclaimed wastewater, sludge) are locally feasible. Finally, the agronomic value of nutrient application depends upon interactions between product chemistry and soil context. For example, alkaline products (e.g., struvite) may be particularly beneficial when applied to acidic soils in Uganda but potentially detrimental in the southwestern United States. The final two objectives reflect the need to develop broadly applicable conceptual frameworks that enumerate possibilities and support holistic and contextual assessment of sanitation options. The first framework characterizes links between resource recovery from sanitation and ecosystem services to shed light on the viability of exploring synergistic interactions between engineered and natural systems. Bridging these fields may create opportunities to support goals related to climate regulation, soil conservation, and water quality, among others. A spatial analysis further demonstrates resource recovery’s potential to contribute to distinct regional ecosystems across the globe. The second framework envisions sanitation as a distinct category of social-ecological system centered on human-derived resources (e.g., nutrients, energy), functioning within an overarching structure of social, economic, and environmental settings. Multiple layers of variables are identified and placed in the framework structure, which is applied to assess alternative sanitation scenarios in a specific context (Bwaise, Uganda) to reveal multi-dimensional tradeoffs and the impacts of individual processes on system outcomes. Overall, this work suggests that resource recovery from sanitation can create numerous opportunities to amplify sustainable development, but a number of local and global issues affect the feasibility and potential impact of various recovery and reuse strategies. Moving forward, integrating the analyses and frameworks developed here and implementing them across various settings can support understanding and decision-making around sanitation and resource recovery to design successful systems and promote a more sustainable future.LimitedAuthor requested closed access (OA after 2yrs) in Vireo ETD syste

Amplifying Progress toward Multiple Development Goals through Resource Recovery from Sanitation

The United Nations’ Sustainable Development Goals (SDGs) recognize that current sanitation gaps must be closed to better serve those without access to safely managed systems (Target 6.2: universal sanitation coverage) and those connected to sewers without wastewater treatment (Target 6.3: halving the proportion of untreated wastewater). Beyond mitigating environmental and health concerns, implementing resource recovery sanitation systems could simultaneously improve the availability of agricultural nutrients (SDG 2) and household energy (SDG 7). This study estimates the potential for global, regional, and country-level resource recovery to impact nutrient and household electricity use through 2030. We distinguish impacts from newly installed sanitation systems (to achieve universal coverage), newly treated wastewater systems (to halve the proportion of untreated wastewater), and existing system replacement, while also considering urban and rural disparities and spatial colocation of nutrients with agricultural needs. This work points toward country-specific strategies for deriving the greatest benefit from sanitation investments while also identifying overarching trends to guide international research efforts. Globally, potential nutrient gains are an order of magnitude larger than electricity (a small fraction of total energy), and considerable impacts are possible in the least-developed countries, six of which could double or offset all projected nutrient and electricity use through newly installed sanitation systems

On the evolution and optimality of emotional states

Moods can be regarded as fluctuating dispositions to make positive and negative evaluations. Developing an evolutionary approach to mood as an adaptive process, we consider the structure and function of such states in guiding behavioural decisions regarding the acquisition of resources and the avoidance of harm in different circumstances. We use a drift diffusion model of decision making to consider the information required by individuals to optimise decisions between two alternatives, such as whether to approach or withdraw from a stimulus that may be life enhancing or life threatening. We show that two dimensions of variation (expectation and preparedness) are sufficient for such optimal decisions to be made. These two dispositional dimensions enable individuals to maximize the overall benefits of behavioural decisions by modulating both the choice made (e.g., approach/withdraw) and decision speed. Such a structure is compatible with circumplex models of subjectively experienced mood and core affect, and provides testable hypotheses concerning the relationships that occur between valence and arousal components of mood in differing ecological niches. The paper is therefore a useful step toward being able to predict moods (and the effect of moods) using an optimality approach

Upper hybrid effects in artificial ionization

A most fascinating result of recent ionospheric experiments has been the discovery of artificial ionization by Pedersen et al. (GRL, 37, L02106, 2010). The Artificial Ionospheric Layers (AIL) were the result of F-region O-mode HF irradiation using the HAARP ionospheric heater operating at 3.6 MW power. As demonstrated by Eliasson et al. (JGR, 117, A10321, 2012) the physics controlling the observed phenomenon and its threshold can be summarized as: "Collisional ionization due to high energy (~ 20 eV) electron tails generated by the interaction of strong Langmuir turbulence with plasma heated at the upper hybrid resonance and transported at the reflection height". The objective of the current presentation is to explore the role of the upper hybrid heating in the formation of AIL and its implications to future experiments involving HF heaters operating in middle and equatorial latitudes